Industry news
This entire item is of approximately 620 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the February 2006 issue of Biomedical Materials and download it online

  • Issue: February 2006, page: 5

    Johnson & Johnson still committed to buying Guidant; declares definitive agreement

    The bidding war between Boston Scientific Corp and Johnson & Johnson (J&J) appeared to be over as of 13 January with the announcement by J&J and Guidant that they have reached an agreement, under which J&J will acquire Guidant for US$24.2 billion in fully diluted equity value. (See also, Boston Scientific, Johnson & Johnson compete to buy Guidant, Biomedical Materials, January 2006, page 5.)

    Read related items on:

          
  • Medical
  • Legal and regulatory
  • Abbott
  • Boston Scientific
  • Guidant
  • J&J
  • Johnson & Johnson

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact